Lyra Therapeutics LYRA

$ 0.18 2.3%

Quarterly report 2024-Q3
added 11-12-2024

Lyra Therapeutics Income Statement 2011-2024 | LYRA

Annual Income Statement Lyra Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	311 M	57.4 M	53.1 M	131 M	-	-	-	-	-	-	-	-	-
Shares	49.8 M	30.2 M	13 M	12.4 M	-	-	-	-	-	-	-	-	-
Historical Prices	6.24	1.9	4.09	10.6	-	-	-	-	-	-	-	-	-
Net Income	-62.7 M	-55.3 M	-43.5 M	-22.1 M	-16.3 M	-6.03 M	-	-	-	-	-	-	-
Revenue	1.56 M	1.36 M	285 K	-	-	1.24 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-67.1 M	-56.3 M	-43.6 M	-22.2 M	-16.5 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-66.8 M	-55.2 M	-42.6 M	-22.1 M	-16.5 M	-7.18 M	-	-	-	-	-	-	-
Operating Expenses	68.7 M	57.7 M	43.9 M	22.2 M	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	19.1 M	17.6 M	14.2 M	9.69 M	4.49 M	3.53 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Lyra Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	65.5 M	65.5 M	64 M	57.2 M	57 M	43.7 M	36.8 M	31.8 M	36.8 M	33.9 M	13 M	13 M	13 M	13 M	12.9 M	12.9 M	12.9 M	8.18 M	231 K	231 K	221 K	186 K	170 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-11.9 M	-48.1 M	-22.5 M	-	-15.7 M	-15.6 M	-16.3 M	-	-14.8 M	-14.4 M	-11.9 M	-	-11.1 M	-11 M	-7.8 M	-	-6.33 M	-4.54 M	-4.23 M	-	-4.16 M	-4.2 M	-3.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	195 K	598 K	532 K	-	544 K	458 K	410 K	-	359 K	525 K	468 K	-	14 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-12.4 M	-49 M	-23.5 M	-	-16.8 M	-16.5 M	-17.3 M	-	-14.8 M	-14.4 M	-11.9 M	-	-11.1 M	-11.1 M	-7.83 M	-	-6.36 M	-4.54 M	-4.25 M	-	-4.23 M	-4.28 M	-3.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-23.4 M	-	-	-	-17 M	-	-14.5 M	-14.1 M	-11.6 M	-	-10.7 M	-10.8 M	-7.76 M	-	-6.33 M	-4.53 M	-4.24 M	-	-4.22 M	-4.28 M	-3.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	12.6 M	49.6 M	24.1 M	-	17.4 M	17 M	17.7 M	-	15.2 M	14.9 M	12.4 M	-	11.1 M	11.1 M	7.83 M	-	6.36 M	4.54 M	4.25 M	-	4.23 M	4.28 M	3.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.93 M	5.14 M	5.82 M	-	5 M	4.57 M	5.13 M	-	5.14 M	4.13 M	3.89 M	-	4.02 M	3.56 M	3.06 M	-	2.65 M	2.44 M	1.28 M	-	1.38 M	865 K	860 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency